Telix Pharmaceuticals (ASX:TLX)
Company Profile
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Telix Pharmaceuticals.
RELATED STOCKHEAD STORIES
Health Check: Little Green Pharma’s European success is more than pot luck
Health Check: Medical device makers Trump drug developers in volatile US healthcare climate
Health Check: Don’t dis-May! ASX biotechs record strong year-on-year share gains
As AI rewires microbiology, Clever Culture’s lab tech is catching Big Pharma’s eye
Health Check: ‘Forgotten’ drug maker AFT Pharma aims high with revenue
Health Check: Compumedics claims world first ‘kids eat for free’ brain scanning breakthrough
Health Check: To chagrin of short sellers, Polynovo shares soar on type 1 diabetes breakthrough
Health Check: Neuren says more patients are staying the course as US Daybue sales lift
Health Check: Investors catch a falling knife as biotech big names bounce from lows
Health Check: Dimerix shares soar as the company hooks the billion-dollar big one in the US
Health Check: Telix licks its wounds after FDA knocks back brain cancer diagnostic
Lunch Wrap: ASX rallies as China teases stimulus; Telix hit by FDA blow
Scott Power: ASX health stocks up in strong start to reporting season
